TACR2 and cervical squamous cell carcinoma: In this subpathway, many GPCRs had significant patterns of expression changes in CESC patients, such as TACR1 (pgene = 9.92e-32), TACR2 (pgene = 3.82e-08), and HTR2B (pgene = 2.76e-26).